Unknown

Dataset Information

0

Formulation and Optimization of Nanospanlastics for Improving the Bioavailability of Green Tea Epigallocatechin Gallate.


ABSTRACT: The present study aimed to investigate the potential of nanospanlastics for boosting the bioavailability of epigallocatechin gallate? (EGCG). EGCG has valuable effects like anti-inflammation, anti-oxidation, and anti-tumorigenesis. Unfortunately, it has a low oral bioavailability due to its limited permeation and poor stability. To overcome these pitfalls, EGCG was fabricated as a nanospanlastic. Nanospanlastics are flexible nanovesicles that are composed of surfactants and edge activators (EAs). EAs improve the deformability of spanlastics by acting as a destabilizing factor of their vesicular membranes. EGCG-loaded spanlastics were prepared by an ethanol injection method, according to 23 factorial design, to explore the impact of different independent variables on entrapment efficiency (EE%), % drug released after 12 h (Q12h), and particle size (PS). In vitro characterization, ex vivo intestinal permeation test, and pharmacokinetic study of the optimized formula were performed. A newly developed RP-HPLC technique was adopted ?for the estimation of EGCG?. The optimized formula (F4) demonstrated more prolonged drug release and a significant improvement in the EE%, permeability, deformability and stability than the corresponding niosomes. The pharmacokinetic study investigated that F4 had a more sustained drug release and a higher bioavailability than the conventional niosomes and free drugs. Nanospanlastics could be a promising approach for improving the bioavailability of EGCG.

SUBMITTER: Mazyed EA 

PROVIDER: S-EPMC7831059 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Formulation and Optimization of Nanospanlastics for Improving the Bioavailability of Green Tea Epigallocatechin Gallate.

Mazyed Eman A EA   Helal Doaa A DA   Elkhoudary Mahmoud M MM   Abd Elhameed Ahmed G AG   Yasser Mohamed M  

Pharmaceuticals (Basel, Switzerland) 20210115 1


The present study aimed to investigate the potential of nanospanlastics for boosting the bioavailability of epigallocatechin gallate‎ (EGCG). EGCG has valuable effects like anti-inflammation, anti-oxidation, and anti-tumorigenesis. Unfortunately, it has a low oral bioavailability due to its limited permeation and poor stability. To overcome these pitfalls, EGCG was fabricated as a nanospanlastic. Nanospanlastics are flexible nanovesicles that are composed of surfactants and edge activators (EAs)  ...[more]

Similar Datasets

| S-EPMC4383035 | biostudies-literature
| S-EPMC8706847 | biostudies-literature
| S-EPMC5245838 | biostudies-literature
| S-EPMC8290267 | biostudies-literature
| S-EPMC7907288 | biostudies-literature
| S-EPMC9289441 | biostudies-literature
| S-EPMC3906112 | biostudies-literature
| S-EPMC3972220 | biostudies-literature
| S-EPMC5504484 | biostudies-other
| S-EPMC3363324 | biostudies-literature